WINTON GROUP Ltd Makes New Investment in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

WINTON GROUP Ltd bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 4th quarter, Holdings Channel.com reports. The fund bought 10,987 shares of the company’s stock, valued at approximately $436,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Wellington Management Group LLP increased its position in Acadia Healthcare by 12.2% in the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after purchasing an additional 1,266,384 shares during the period. Magnetar Financial LLC grew its position in shares of Acadia Healthcare by 385.4% during the 4th quarter. Magnetar Financial LLC now owns 928,772 shares of the company’s stock worth $36,826,000 after buying an additional 737,427 shares during the period. Holocene Advisors LP raised its stake in shares of Acadia Healthcare by 201.5% during the third quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock worth $61,667,000 after buying an additional 649,997 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after buying an additional 454,044 shares during the period. Finally, Beach Point Capital Management LP bought a new position in Acadia Healthcare in the fourth quarter valued at approximately $14,097,000.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $30.12 on Monday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare Company, Inc. has a 52 week low of $27.61 and a 52 week high of $82.41. The company’s 50 day moving average price is $37.14 and its two-hundred day moving average price is $44.83. The company has a market capitalization of $2.80 billion, a P/E ratio of 9.88, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on ACHC. KeyCorp cut their price target on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Monday, March 3rd. Bank of America cut their target price on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price target for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Royal Bank of Canada reduced their price objective on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. Finally, Mizuho lowered their target price on shares of Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a research note on Tuesday, March 25th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $52.19.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.